Aerovate Therapeutics Quote - AVTE

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

2.47

Bid

1.26

Ask

2.65

Volume

62,965

2.45 Day's Range 2.64

1.25 52 Week Range 32.415

Market Cap

71.32M

Previous Close

2.57

Open

2.5101

Last Trade

2.38

Last Trade Time

Financial Volume

US$ 157,828

VWAP

2.5066

Average Volume (3m)

220,821

Shares Outstanding

28,874,513

Dividend Yield

PE Ratio

-0.94

Earnings Per Share (EPS)

-2.62

Revenue

Net Profit

-75.52M

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hyper... Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aerovatetx.com

Headquarters

Wilmington, Delaware, USA

Founded

Aerovate Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AVTE. The last closing price for Aerovate Therapeutics was US$2.57. Over the last year, Aerovate Therapeutics shares have traded in a share price range of US$ 1.25 to US$ 32.415.

Aerovate Therapeutics currently has 28,874,513 shares outstanding. The market capitalization of Aerovate Therapeutics is US$74.21 million. Aerovate Therapeutics has a price to earnings ratio (PE ratio) of -0.94.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.135	-5.18234165067	2.605	2.68	2.46	79546	2.59523834	CS
4	-0.17	-6.43939393939	2.64	2.68	2.4	254897	2.5293096	CS
12	-0.1	-3.89105058366	2.57	2.73	2.4	220821	2.57929879	CS
26	0.8	47.9041916168	1.67	3	1.62	495855	2.40949389	CS
52	-17.51	-87.6376376376	19.98	32.415	1.25	572014	4.36312134	CS
156	-6.83	-73.4408602151	9.3	32.415	1.25	249001	7.68529272	CS
260	-25.53	-91.1785714286	28	32.415	1.25	225825	8.3888063	CS

AVTE - Frequently Asked Questions (FAQ)

What is the current Aerovate Therapeutics share price?

The current share price of Aerovate Therapeutics is US$ 2.47

How many Aerovate Therapeutics shares are in issue?

Aerovate Therapeutics has 28,874,513 shares in issue

What is the market cap of Aerovate Therapeutics?

The market capitalisation of Aerovate Therapeutics is USD 74.21M

What is the 1 year trading range for Aerovate Therapeutics share price?

Aerovate Therapeutics has traded in the range of US$ 1.25 to US$ 32.415 during the past year

What is the PE ratio of Aerovate Therapeutics?

The price to earnings ratio of Aerovate Therapeutics is -0.94

What is the reporting currency for Aerovate Therapeutics?

Aerovate Therapeutics reports financial results in USD

What is the latest annual profit for Aerovate Therapeutics?

The latest annual profit of Aerovate Therapeutics is USD -75.52M

What is the registered address of Aerovate Therapeutics?

The registered address for Aerovate Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the Aerovate Therapeutics website address?

The website address for Aerovate Therapeutics is www.aerovatetx.com

Which industry sector does Aerovate Therapeutics operate in?

Aerovate Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MGOLMGO Global Inc	US$ 0.4191 (126.54%)	816.59M
CDTConduit Pharmaceuticals Inc	US$ 2.831 (82.65%)	144.17M
GSIWGarden Stage Ltd	US$ 0.79 (78.73%)	219.64M
TOIIWOncology Institute Inc	US$ 0.033 (58.88%)	7.27k
CYTHCyclo Therapeutics Inc	US$ 1.19 (54.55%)	84.73M
FTELFitell Corporation	US$ 2.70 (-57.01%)	2.3M
SGBXSafe and Green Holdings Corporation	US$ 0.6401 (-44.82%)	5.65M
NKLANikola Corporation	US$ 0.4432 (-41.10%)	52.44M
PLRXPliant Therapeutics Inc	US$ 7.785 (-34.85%)	6.44M
LIPOLipella Pharmaceuticals Inc	US$ 3.08 (-33.76%)	2.2M
MGOLMGO Global Inc	US$ 0.4191 (126.54%)	816.59M
RIMEAlgorhythm Holdings Inc	US$ 0.0169 (-20.66%)	274.2M
NVDANVIDIA Corporation	US$ 129.84 (0.90%)	228.2M
GSIWGarden Stage Ltd	US$ 0.79 (78.73%)	219.64M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0537 (14.74%)	212.29M